Healthcare Services Group, Inc. Reports Q4 & 2018 Results, Progress On Near Term Priorities, and Q4 Cash Dividend Increase
February 05 2019 - 4:15PM
Healthcare Services Group, Inc. (NASDAQ:HCSG) (the “Company”)
reported that revenues for the three months ended December 31, 2018
were $496 million compared to $499 million for the same period in
2017. Revenues for the year ended December 31, 2018 increased to
$2.01 billion compared to $1.87 billion for the same period in
2017. Net income for the quarter was $32 million, or $0.43 per
basic and $0.42 per diluted common share, and segment margins in
housekeeping & laundry and dining & nutrition services are
estimated at 9.5% and 5.4%, respectively. Cash flow from operations
for the quarter was $5 million, inclusive of the $21 million change
in accrued payroll and $80 million for the year, including $52
million in the second half of the year.
During the fourth quarter, the Company continued
to make significant progress on its near-term priorities of:
- Implementing and adhering to its facility level operating
systems, which ensures that customer service, experience and
financial performance are in line with both Company and customer
commitments. The Company exited the year with strong operating
momentum and expects its cost of services to return to historical
levels of 86% or better in 2019.
- Strengthening customer payment terms and conditions, which
includes increasing customer payment frequency from monthly to
semimonthly or weekly. To date, the Company has successfully
transitioned over 40% of its customers to an accelerated payment
model and expects to further that trend in 2019.
- Replenishing the management pipeline, to ensure it is well
prepared for future growth and expansion. The Company enters the
new year having significantly grown its management pipeline over
the past few months and expects to continue its heightened focus on
hiring and developing management candidates through the first half
of 2019.
In line with its near-term priorities and
similar to last quarter’s housekeeping & laundry contract
initiative, the Company adjusted its contractual relationships with
several dining customers during the quarter, the most significant
of which was Genesis Healthcare® (“Genesis”). Effective December 1,
2018, Genesis assumed responsibility for direct payment to
suppliers for food purchases. HCSG will continue to manage food
procurement, and as a result, maintain the same benefits of
purchasing scale. The Company expects these changes to decrease
dining & nutrition segment revenues and food-related purchases
by approximately $20 million per quarter (with one-third of the
impact reflected in Q4).
Direct cost of services is reported at $425
million, or 85.7%, and included a $15 million benefit related to
favorable workers compensation loss development trends, as the
Company continues to successfully execute on its strategy of
reducing claim frequency, scope and severity. It expects to
continue to realize operational and financial efficiencies related
to its property and casualty programs in 2019 and beyond. Direct
cost for the quarter was also impacted by $9 million of increased
accounts receivable reserves, primarily related to the corporate
restructurings of two privately held operators. The Company will
continue to pursue outstanding claims related to these matters.
Direct cost for the quarter was also impacted by elevated payroll
costs related to the Company’s investment in its management
training ramp-up.
Selling, general and administrative (“SG&A”)
was reported at 6.4%, but after adjusting for the $4.1 million
change in deferred compensation, actual SG&A was 7.3%. During
the quarter, SG&A was impacted by approximately $1 million of
costs related to the replacement and expansion of its credit
facility, finalized during the fourth quarter, as well as increases
in professional fees from technology investments related to the
January 1, 2019 transition from its legacy finance and accounting
platform to the Workday® financial management module. The Company
expects SG&A to approximate 7% in the year ahead with the
ongoing opportunity to garner additional efficiencies.
The Company’s effective tax rate was 9.9% and
16.4% for the quarter and year, respectively and was impacted by
the timing and amount of the Worker Opportunity Tax Credit
(“WOTC”), state-specific tax credits and other discrete items. The
Company expects its 2019 tax rate to approximate 21% to 23%,
including WOTC, but excluding other discrete items that impacted
its 2018 rate.
In addition, the Company’s Board of Directors
declared a quarterly cash dividend of $0.19625 per common share,
payable on March 22, 2019 to shareholders of record at the close of
business on February 15, 2019. This represents the 63rd consecutive
quarterly cash dividend payment, as well as the 62nd consecutive
increase since the initiation of quarterly cash dividend payments
in 2003.
The Company will host a conference call on
Wednesday, February 6, 2019, at 8:30 a.m. Eastern Time to discuss
its results for the three months and year ended December 31, 2018.
The call may be accessed via phone at 800-893-5360. The call will
be simultaneously webcast under the “Events & Presentations”
section of the Investor Relations page on the Company’s website,
www.hcsg.com. A replay of the webcast will also be available on our
website for one year following the date of the earnings call.
The Company also announced that it will present
at Oppenheimer's 29th Annual Healthcare Conference on March 20,
2019 at the Westin New York Grand Central in New York City, New
York.
Cautionary Statement Regarding
Forward-Looking Statements
This release and any schedules incorporated by
reference into it may contain forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933, as amended,
and Section 21E of the Securities Exchange Act of 1934, as amended,
which are not historical facts but rather are based on current
expectations, estimates and projections about our business and
industry, and our beliefs and assumptions. Words such as
“believes,” “anticipates,” “plans,” “expects,” “will,” “goal,” and
similar expressions are intended to identify forward-looking
statements. The inclusion of forward-looking statements should not
be regarded as a representation by us that any of our plans will be
achieved. We undertake no obligation to publicly update or revise
any forward-looking statements, whether as a result of new
information, future events or otherwise. Such forward-looking
information is also subject to various risks and uncertainties.
Such risks and uncertainties include, but are not limited to, risks
arising from our providing services exclusively to the healthcare
industry, primarily providers of long-term care; having a
significant portion of our consolidated revenues contributed by one
customer during the year ended December 31, 2018; credit and
collection risks associated with the healthcare industry; our
claims experience related to workers’ compensation and general
liability insurance; the effects of changes in, or interpretations
of laws and regulations governing the healthcare industry, our
workforce and services provided, including state and local
regulations pertaining to the taxability of our services and other
labor-related matters such as minimum wage increases;the Company's
expectations with respect to selling, general, and administrative
expense; continued realization of tax benefits arising from our
corporate reorganization and self-funded health insurance program;
risks associated with the reorganization of our corporate
structure;realization of our expectations regarding the impact of
the Tax Cuts and Jobs Act on our financial results; and the risk
factors described in Part I of our Form 10-K for the fiscal year
ended December 31, 2017 under “Government Regulation of Clients,”
“Competition” and “Service Agreements and Collections,” and under
Item IA. “Risk Factors” in such Form 10-K.
These factors, in addition to delays in payments
from clients and/or clients in bankruptcy or clients with which we
are in litigation to collect payment, have resulted in, and could
continue to result in, significant additional bad debts in the near
future. Additionally, our operating results would be adversely
affected if unexpected increases in the costs of labor and
labor-related costs, materials, supplies and equipment used in
performing services (including the impact of potential tariffs)
could not be passed on to our clients.
In addition, we believe that to improve our
financial performance we must continue to obtain service agreements
with new clients, retain and provide new services to existing
clients, achieve modest price increases on current service
agreements with existing clients and maintain internal cost
reduction strategies at our various operational levels.
Furthermore, we believe that our ability to sustain the internal
development of managerial personnel is an important factor
impacting future operating results and the successful execution of
our projected growth strategies.
Company Contacts: |
|
|
|
Theodore Wahl |
|
Matthew J. McKee |
President and Chief Executive Officer |
|
Chief
Communications Officer |
|
|
|
215-639-4274 |
investor-relations@hcsgcorp.com |
HEALTHCARE SERVICES GROUP,
INC.CONSOLIDATED STATEMENTS OF
INCOME(Unaudited)(in thousands, except per
share data) |
|
|
For the Three Months Ended |
|
For the Year Ended |
|
December 31, |
|
December 31, |
|
2018 |
|
|
2017 |
|
2018 |
|
|
2017 |
Revenues |
$ |
496,408 |
|
|
$ |
499,410 |
|
$ |
2,008,821 |
|
|
$ |
1,866,131 |
Operating costs and
expenses: |
|
|
|
|
|
|
|
Cost of
services provided |
425,256 |
|
|
432,694 |
|
1,771,981 |
|
|
1,612,510 |
Selling,
general and administrative |
31,995 |
|
|
33,591 |
|
136,603 |
|
|
126,732 |
Income from
operations |
39,157 |
|
|
33,125 |
|
100,237 |
|
|
126,889 |
Other (expense)
income: |
|
|
|
|
|
|
|
Investment and interest |
(4,150) |
|
|
1,553 |
|
(327) |
|
|
6,076 |
Income before income
taxes |
35,007 |
|
|
34,678 |
|
99,910 |
|
|
132,965 |
Income taxes |
3,455 |
|
|
14,492 |
|
16,386 |
|
|
44,739 |
|
|
|
|
|
|
|
|
Net income |
$ |
31,552 |
|
|
$ |
20,186 |
|
$ |
83,524 |
|
|
$ |
88,226 |
|
|
|
|
|
|
|
|
Basic earnings per
common share |
$ |
0.43 |
|
|
$ |
0.27 |
|
$ |
1.13 |
|
|
$ |
1.20 |
|
|
|
|
|
|
|
|
Diluted earnings per
common share |
$ |
0.42 |
|
|
$ |
0.27 |
|
$ |
1.12 |
|
|
$ |
1.19 |
|
|
|
|
|
|
|
|
Cash dividends declared
per common share |
$ |
0.19625 |
|
|
$ |
0.19125 |
|
$ |
0.77750 |
|
|
$ |
0.75750 |
|
|
|
|
|
|
|
|
Basic weighted average
number of common shares outstanding |
74,092 |
|
|
73,601 |
|
74,002 |
|
|
73,355 |
|
|
|
|
|
|
|
|
Diluted weighted
average number of common shares outstanding |
74,653 |
|
|
74,631 |
|
74,612 |
|
|
74,348 |
|
|
|
|
|
|
|
|
|
|
HEALTHCARE SERVICES GROUP,
INC.CONDENSED CONSOLIDATED BALANCE
SHEETS(Unaudited)(in
thousands) |
|
|
December 31, 2018 |
|
December 31, 2017 |
Cash and cash
equivalents |
$ |
26,025 |
|
$ |
9,557 |
Marketable securities,
at fair value |
76,362 |
|
73,221 |
Accounts and notes
receivable, net |
341,838 |
|
378,720 |
Other current
assets |
63,911 |
|
65,908 |
Total
current assets |
508,136 |
|
527,406 |
|
|
|
|
Property and equipment,
net |
12,900 |
|
13,509 |
Notes receivable - long
term |
43,043 |
|
15,476 |
Goodwill |
51,084 |
|
51,084 |
Other intangible
assets, net |
26,518 |
|
30,881 |
Deferred compensation
funding |
29,113 |
|
28,885 |
Other assets |
21,809 |
|
8,762 |
Total assets |
$ |
692,603 |
|
$ |
676,003 |
|
|
|
|
Accrued insurance
claims - current |
$ |
20,696 |
|
$ |
22,245 |
Other current
liabilities |
142,695 |
|
162,225 |
Total
current liabilities |
163,391 |
|
184,168 |
|
|
|
|
Accrued insurance
claims - long term |
58,904 |
|
62,454 |
Deferred compensation
liability |
29,528 |
|
29,429 |
Stockholders'
equity |
440,780 |
|
399,952 |
Total liabilities and
stockholders' equity |
$ |
692,603 |
|
$ |
676,003 |
|
|
|
|
|
|
Healthcare Services (NASDAQ:HCSG)
Historical Stock Chart
From Jun 2024 to Jul 2024
Healthcare Services (NASDAQ:HCSG)
Historical Stock Chart
From Jul 2023 to Jul 2024